Liver Diseases  >>  lamivudine  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lamivudine / Generic mfg.
NCT01376154: Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)

Completed
N/A
342
NA
Lamivudine
GlaxoSmithKline
Hepatitis B, Chronic
12/09
02/11
LAMGR, NCT01128686: Lamivudine(LAM) Good Responder Study

Completed
N/A
1
RoW
No intervention
ViiV Healthcare, GlaxoSmithKline
Hepatitis B, Chronic
06/11
06/11
NCT01705704: A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Completed
N/A
269
Europe, RoW
Hoffmann-La Roche
Hepatitis B, Chronic
02/13
02/13

Download Options